Vicuron Submits NDA For Additional Anidulafungin Indication

The invasive candidiasis/candidemia indication was spun off from a pending NDA for esophageal candidiasis.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet